Core Viewpoint - NanoVibronix, Inc. experienced a significant stock surge of 71.80 percent to $11.15 following the announcement of a new patent for its subsidiary ENvue Medical Holdings LLC, enhancing its position in non-invasive therapeutic systems [1] Stock Performance - The stock opened at $9.43 and fluctuated between $8.86 and $17.40, compared to a previous close of $6.49 on the Nasdaq [1] - Trading volume increased dramatically to 51.6 million shares, significantly higher than the average of 171,842 shares [2] - NanoVibronix's stock is currently within a 52-week range of $4.71 to $162.50 [2] Patent Announcement - The U.S. Patent No. 12,409,105 B2 was issued for the "Insertion Device Positioning Guidance System and Method," which strengthens NanoVibronix's patent portfolio [1]